Partly in response to the so-called ‘reproducibility crisis’ in science, researchers are embracing a set of practices that aim to make the whole endeavor more transparent, more reliable – and better.
It’s a problem when much of what winds up in scientific journals isn’t replicable, for various reasons. The research community is taking baby steps toward addressing the “reproducibility crisis.”
Direct links between universities and industry funders pose significant risks – but can they be managed?
Shannon Kringen/Flickr
Paul Komesaroff, Monash University e Ken Harvey, Monash University
The University of Sydney’s announcement of a role funded by the Blackmores Institute raises perennial questions about whether industry-funded research can be truly independent.
In 2010, the European Ombudsman ruled that the European Medicines Agency should open access to clinical trials data when companies applied to get their drugs on the market. The ombudsman decided public…
The current debate obscures the much larger question of why doctors need to receive “tea and biscuits” from pharmaceutical companies at all.
Yortw/Flickr
The Australian Medical Association (AMA) and medical specialist groups are currently debating public disclosure of gifts received by doctors from pharmaceutical companies. The bone of contention is how…
Tamiflu was stockpiled amid flu outbreaks and scares.
Rui Vieira/PA
Are you worried about how decisions involving public money are made? You should be. Last week, the National Audit Office disclosed that the Department of Health spent £424 million on the anti-flu drug…
Reform of medical regulations has become a hot potato being passed from one agency to another.
eltpics/Flickr
Two bills in the national parliament provide a snapshot of our health regulatory system, and just like a smoker’s lungs, it’s not a pretty picture. The bills show that we’re slow in fixing regulatory incapacity…
Roche has refused to share clinical trial data for Tamiflu, which is used to relieve symptoms and reduce complications of influenza.
AAP/Joe Castro
A study published today shows that clinical trials with industry sponsorship report greater benefits and fewer harmful side effects. In the discussion, the authors note that most reviews and guidelines…
Post-marketing studies are often used as ploys to get doctors in the habit of prescribing expensive new medicines.
Flickr / Nestle
New medicines are often marketed on the basis of clinical trials of limited size and duration. So clinical studies of a medicine after it has reached the market (post-marketing studies) can be a useful…
A fundamental change in the relationship between industry and medical professionals is needed.
flickr/buddawiggi
TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
Medicines Australia’s code of conduct governs the promotion of prescription drugs and the relationship of industry to health professionals.
LadyofProcrastination/Wikimedia Commons
TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
Guidelines help doctors decide on the best way to treat patients.
Jocelyn Augustino/FEMA News Photo
Elim Papadakis, National Health and Medical Research Council
TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
The business and medical worlds are replete with examples of unethical conduct when it comes to accepting and giving gifts.
Li'l Wolf
Linda Brennan, RMIT University e Ken Harvey, La Trobe University
TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
Most surveyed patients said they’d have more confidence in their doctor’s decisions with full disclosure of competing interests.
AAP Image/Alan Porritt
TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
The obligation to tell patients about medical mistakes is clear but we don’t know whether it’s complied with.
hang_in_there/Flickr
TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
SKB knew eight adolescents self-harmed or reported emergent suicidal ideas compared to only one in the placebo group but hid this.
Michael Valli
TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
Vioxx is the quintessential story of what can go wrong when a big pharmaceutical company exerts influence over the evidence base.
AAP
TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
Acknowledging that things don’t always go right, and trying to figure out what went wrong are hallmarks of a transparent and mature profession.
AAP
TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney
Adjunct Clinical Associate Professor, AMREP Department of Medicine, Alfred Hospital, Melbourne & Senior Medical Oncologist and Palliative Care Physician, Melbourne Oncology Group, Cabrini Haematology and Oncology Centre, Wattletree Road, Malvern, Monash University